The present work describes the synthesis and spectral analysis of some new 3(Z)-{4-[4-(arylsulfonyl)piperazin-1-ylbenzylidene)-1,3-dihydro-2H-indol-2-one (5a-j). Ten of the synthesized compounds were screened in vitro against six species of microorganisms, Staphylococcus aureus, Streptococcus pyogenes, Escherichia coli, Pseudomonas aeruginosa, Asperigellus niger and Asperigellus clavatus. Most of the compounds exhibited significant antimicrobial activity. All of these compounds were also screened in vitro for the antioxidant activity using DPPH assay. Most of them have shown very significant antioxidant activity.
Oxindole and other related ring systems, have several interesting biological activities [1] [2] [3] [4] . According to the literature survey, 1-substituted aminomethyl-3-cyclohexylthiosemicarbazone-2-indolinones have shown significant antifungal, antibacterial and antiviral activities both in vivo and in vitro [5] . The new 1,3-dihydro-3-hydroxy-3-[2-hydroxyimino-2-(substituted phenyl)ethyl]-2H-indol-2-ones were synthesized and tested for antimicrobial activity and majority of the compounds were found to exhibit promising antibacterial and antifungal activities [6] . 3-amino-1-hydroxy-oxindole and related compounds have found to show significant antimicrobial activity [7] . Oxindole and related indole derivatives have also been found to show very good antioxidant activity [8, 9] . Sulfonamide based drugs are known for their antimicrobial activities [10] . Arylsulfonamide-oxindole hybrid [11] has been explored for their anticancer activity, but few attempts have been made to explore the antimicrobial and antioxidant activity of aryl sulfonamide-oxindole hybrid. We herein, report the synthesis and biological testing of some 3(Z)-{4- [4-(arylsulfonyl) piperazin-1-ylbenzylidene)-1,3-dihydro-2H-indol-2-ones. These sulfonamide based oxindole derivatives were tested for antibacterial, antifungal and antioxidant activity.
All the recorded melting points were determined in open capillary and are uncorrected. IR spectra were recorded on Perkin-Elmer FTIR spectrophotometer in KBr disc.
1 H NMR and 13 C NMR spectra were recorded on 400 MHz spectrophotometer in DMSO-d 6 as a solvent and TMS as an internal standard. Peak values are shown in δ ppm. Mass spectra were obtained using a Waters mass spectrometer.
General procedure for the synthesis of t-butyl-4-{4[(Z)-(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl] phenyl}piperazine-1-carboxylate (3) used was as follows; a mixture of 1 (0.01 mol) and 2 (0.01 mol) was dissolved in toluene and ammonium acetate (0.03 mol) was added to it. The reaction mixture stirred at 80º for 6 h. The reaction mixture was cooled to room temperature and poured into Hexane. Solid obtained was separated by filtration and crystallized from alcohol. General procedure for the synthesis of (3Z)-3-(4-piperazin-1-ylbenzylidene)-1, 3-dihydro-2H-indol-2-one (4) was as follows, compound 3 (0.01 mol) was dissolved in 10 ml methylene dichloride and 3 ml trifluoroacetic acid was added slowly to the reaction mixture (Scheme 1). The reaction mixture stirred at room temperature for 3 h and concentrated under vacuum. The reaction mixture was basified by liquor NH 3 and extracted by ethyl acetate. Ethyl acetate layer separated, dried over Na 2 SO 4 and concentrated under vacuum.
General procedure for the synthesis of 5 (a-j) was as follows; compound 4 (0.01 mol) and aromatic sulfonyl chloride (0.01 mol) were dissolved in tetrahydrofuran in presence of pyridine (0.03 mol) and catalytic amount of dimethyl aminopyridine. The reaction mixture was stirred at room temperature for 8 h and then poured into water. Aqueous layer extracted by ethyl acetate. Ethyl acetate layer separated, dried over Na 2 SO 4 and concentrated under vacuum. The crude product obtained, was crystallized by alcohol. The Melting point and yield of the 5 (a-j) is given in The in vitro antimicrobial activity of test compounds was assessed against 24 h cultures of several selected bacteria and fungi. The gram positive and gramnegative bacteria used were E. coli, P. aeruginosa, S. pyogenes and S. aureus and the fungi used were A. niger and A. clavatus. Antimicrobial activity of all the compounds was tested using Muller Hinton broth (Hi Media M 391) medium. The activity is reported by measuring the diameter of inhibition in millimeter (mm). The tested compounds show significant antifungal and antibacterial activity as shown in Table 2 and 3. Compounds 5a, 5c, 5e and 5g have shown very good antifungal as well as antibacterial activity, while 5f, 5h and 5j show very low antifungal activity. Except 5e, all other compounds with alkyl substituent viz. 5d, 5h and 5j show very low antifungal activity. Almost all the compounds show moderate activity against bacterial strains at 250 µg/ ml concentration.
The in vitro antioxidant activity of the test compounds was determined by DPPH method by using L-ascorbic 25  50  100  250  25  50  100  250  25  50  100  250  25  50  100  250  Ampicillin  15  16  19  20  15  15  18  20  14  16  18  19  13  14  16  20  Ciprofloxacin  23  28  28  28  23  24  26  27  19  21  21  22  19  21  22  22  Norfloxacin  25  26  27  29  19  21  23  23  19  20  21  21  22  25  26  28  5a  11  14  16   22   12  14  16   17   12  13  17  20  10  13  15   17   5b  11  12  14  16  14  17  18  20  13  17  19  23  12  13  14   17   5c  14  17  20  22  12  13  16  19  14  16  18  21  13  14  17   21   5d  12  15  16  19  14  15  16  17  14  16  18  21  13  14  17   21   5e  15  17  19  24  12  15  18  20  12  14  17  20  12  14 Griseofulvin  23  25  25  28  21  22  22  24  Nystatin  19  24  29  29  21  24  25  26  5a  12  14  16  21  12  14  15  18  5b  11  13  17  22  11  12  14  16  5c  13  15  19  20  13  14  17  21  5d  11  13  15  16  11  12  14  16  5e  12  15  16  20  10  14  16  22  5f  -11  12  14  -11  12  12  5g  12  15  18  21  12  15  16  18  5h  -11  13  15  --10  11  5i  12  14  16  21  12  14  15  18  5j  10  11  12  14  -11  12  12 Zone of inhibition (in mm) excluding well size 6 mm acid (an antioxidant agent) as a positive control. The compounds were tested for antioxidant activity at 200, 100 and 50 µg/ml concentrations. Amongst the compounds screened for antioxidant activity, 5b, 5c, 5f, 5g and 5i showed very good antioxidant activities as shown in Table 4 . Compounds 5a, 5d, 5e, 5h and 5j do not show significant antioxidant activity. The compounds with alkyl substituent do not show any radical scavenging activity while the compounds with heterocyclic ring system like coumarin or the one with substituents like N(CH 3 ) 2, OCF 3 and N-acetyl show very significant antioxidant activity. It suggests the significant role played by these substituents as radical scavengers.
In conclusion, a series of oxindole derivatives were synthesized and tested for antifungal, antibacterial and antioxidant activity. Most of the compounds have shown very good antimicrobial and antioxidant activity, which suggest a possible clinical significance of 3(Z)-{4-[4-(arylsulfonyl)piperazin-1-ylbenzylidene)-1,3-dihydro-2H-indol-2-ones.
